AngioDynamics (ANGO) Tops Q3 EPS by 4c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ACCV
4. AZN
5. FICO
6. GMAB
7. QQQ
8. SPCX
9. APO
10. SMMT

Go back to AngioDynamics (ANGO) Tops Q3 EPS by 4c, Offers Guidance

AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance

March 30, 2021 7:00 AM EDT

Fiscal 2021 Third Quarter Highlights

Net sales of $71.2 million increased 2.0% compared to the prior-year quarter Gross margin of 54.1%, a decline of 370 basis points year over year GAAP loss per share of $0.09 and adjusted earnings per share of $0.02 Cash and cash equivalents on February 28, 2021 were $54.5 million The Company is raising its fiscal year 2021 guidance. The Company now expects net sales between $285 and $288 million and fiscal year 2021 adjusted earnings per share between $0.04 and $0.06

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ:... More